Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?

被引:22
作者
Fay, Andre P. [1 ,2 ]
Antonarakis, Emmanuel S. [3 ,4 ]
机构
[1] Pontificia Univ Catolica Rio Grande do Sul, Sao Lucas Hosp, Sch Med, Porto Alegre, RS, Brazil
[2] Oncoclin Inst, Sao Paulo, Brazil
[3] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[4] Johns Hopkins Univ, Brady Urol Inst, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
TUMOR-CELLS; OPEN-LABEL; IMMUNOTHERAPY; MITOXANTRONE; RADIOTHERAPY; MULTICENTER; PREDNISONE; IPILIMUMAB; SURVIVAL; PD-L1;
D O I
10.21037/atm.2019.01.37
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 30 条
[1]   Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer [J].
Antonarakis, Emmanuel S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11) :1087-1089
[2]  
Boudadi Karim, 2018, Oncotarget, V9, P28561, DOI 10.18632/oncotarget.25564
[3]   Comprehensive Analysis of Hypermutation in Human Cancer [J].
Campbell, Brittany B. ;
Light, Nicholas ;
Fabrizio, David ;
Zatzman, Matthew ;
Fuligni, Fabio ;
de Borja, Richard ;
Davidson, Scott ;
Edwards, Melissa ;
Elvin, Julia A. ;
Hodel, Karl P. ;
Zahurancik, Walter J. ;
Suo, Zucai ;
Lipman, Tatiana ;
Wimmer, Katharina ;
Kratz, Christian P. ;
Bowers, Daniel C. ;
Laetsch, Theodore W. ;
Dunn, Gavin P. ;
Johanns, Tanner M. ;
Grimmer, Matthew R. ;
Smirnov, Ivan V. ;
Larouche, Valerie ;
Samuel, David ;
Bronsema, Annika ;
Osborn, Michael ;
Stearns, Duncan ;
Raman, Pichai ;
Cole, Kristina A. ;
Storm, Phillip B. ;
Yalon, Michal ;
Opocher, Enrico ;
Mason, Gary ;
Thomas, Gregory A. ;
Sabel, Magnus ;
George, Ben ;
Ziegler, David S. ;
Lindhorst, Scott ;
Issai, Vanan Magimairajan ;
Constantini, Shlomi ;
Toledano, Helen ;
Elhasid, Ronit ;
Farah, Roula ;
Dvir, Rina ;
Dirks, Peter ;
Huang, Annie ;
Galati, Melissa A. ;
Chung, Jiil ;
Ramaswamy, Vijay ;
Irwin, Meredith S. ;
Aronson, Melyssa .
CELL, 2017, 171 (05) :1042-+
[4]  
Crawford ED, 2015, CAN J UROL, V22, P8048
[5]   KEYNOTE-199: Pembrolizumab (pembro) for docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC). [J].
De Bono, Johann S. ;
Goh, Jeffrey C. H. ;
Ojamaa, Kristiina ;
Rodriguez, Jose Maria Piulats ;
Drake, Charles G. ;
Hoimes, Christopher J. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[6]   Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [J].
de Bono, Johann Sebastian ;
Oudard, Stephane ;
Ozguroglu, Mustafa ;
Hansen, Steinbjorn ;
Machiels, Jean-Pascal ;
Kocak, Ivo ;
Gravis, Gwenaelle ;
Bodrogi, Istvan ;
Mackenzie, Mary J. ;
Shen, Liji ;
Roessner, Martin ;
Gupta, Sunil ;
Sartor, A. Oliver .
LANCET, 2010, 376 (9747) :1147-1154
[7]   Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer [J].
Drake, Charles G. ;
Lipson, Evan J. ;
Brahmer, Julie R. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (01) :24-37
[8]   CTLA-4: new insights into its biological function and use in tumor immunotherapy [J].
Egen, JG ;
Kuhns, MS ;
Allison, JP .
NATURE IMMUNOLOGY, 2002, 3 (07) :611-618
[9]   Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer [J].
Graff, Julie N. ;
Alumkal, Joshi J. ;
Drake, Charles G. ;
Thomas, George V. ;
Redmond, William L. ;
Farhad, Mohammad ;
Cetnar, Jeremy P. ;
Ey, Frederick S. ;
Bergan, Raymond C. ;
Slottke, Rachel ;
Beer, Tomasz M. .
ONCOTARGET, 2016, 7 (33) :52810-52817
[10]   Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer [J].
Haffner, Michael C. ;
Guner, Gunes ;
Taheri, Diana ;
Netto, George J. ;
Palsgrove, Doreen N. ;
Zheng, Qizhi ;
Guedes, Liana Benevides ;
Kim, Kunhwa ;
Tsai, Harrison ;
Esopi, David M. ;
Lotan, Tamara L. ;
Sharma, Rajni ;
Meeker, Alan K. ;
Chinnaiyan, Arul M. ;
Nelson, William G. ;
Yegnasubramania, Srinivasan ;
Luo, Jun ;
Mehra, Rohit ;
Antonarakis, Emmanuel S. ;
Drake, Charles G. ;
de Marzo, Angelo M. .
AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (06) :1478-1485